Cargando…
Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression
BACKGROUND: Circular RNAs (circRNAs) dysregulation has been revealed to function in the pathological processes of cancers. Herein, the role and mechanisms of hsa_circ_0002082 in breast cancer (BC) progression were elucidated. METHODS: In vivo and in vitro functional experiments were conducted, and t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701879/ https://www.ncbi.nlm.nih.gov/pubmed/36161346 http://dx.doi.org/10.1002/jcla.24697 |
_version_ | 1784839639083778048 |
---|---|
author | Liu, Yu Liu, Yun Luo, Jinyong Zhao, Wen Hu, Chunhui Chen, Gongquan |
author_facet | Liu, Yu Liu, Yun Luo, Jinyong Zhao, Wen Hu, Chunhui Chen, Gongquan |
author_sort | Liu, Yu |
collection | PubMed |
description | BACKGROUND: Circular RNAs (circRNAs) dysregulation has been revealed to function in the pathological processes of cancers. Herein, the role and mechanisms of hsa_circ_0002082 in breast cancer (BC) progression were elucidated. METHODS: In vivo and in vitro functional experiments were conducted, and the interaction between miR‐508‐3p and hsa_circ_0002082 or Centromere Protein F (CENPF) was elucidated. RESULTS: Hsa_circ_0002082 expression was higher in BC tissues and cell lines. Functionally, knockdown of hsa_circ_0002082 induced apoptosis and suppressed proliferation and metastasis in BC cells in vitro. Mechanistically, hsa_circ_0002082 targeted miR‐508‐3p, which was confirmed to be decreased in BC. MiR‐508‐3p overexpression suppressed BC cell malignant phenotypes, moreover, inhibition of miR‐508‐3p attenuated the anticancer action of hsa_circ_0002082 silencing on BC cells. Besides that, miR‐508‐3p targeted CENPF, CENPF was highly expressed in BC, CENPF up‐regulation reversed the suppressive impacts of miR‐508‐3p on BC cell growth and metastasis. Besides, hsa_circ_0002082 silencing impeded BC growth in nude mice. CONCLUSION: Knockdown of hsa_circ_0002082 suppresses breast cancer growth and metastasis by miR‐508‐3p/CENPF axis, suggesting that hsa_circ_0002082 may be a promising target for breast cancer treatment. |
format | Online Article Text |
id | pubmed-9701879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97018792022-11-28 Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression Liu, Yu Liu, Yun Luo, Jinyong Zhao, Wen Hu, Chunhui Chen, Gongquan J Clin Lab Anal Research Articles BACKGROUND: Circular RNAs (circRNAs) dysregulation has been revealed to function in the pathological processes of cancers. Herein, the role and mechanisms of hsa_circ_0002082 in breast cancer (BC) progression were elucidated. METHODS: In vivo and in vitro functional experiments were conducted, and the interaction between miR‐508‐3p and hsa_circ_0002082 or Centromere Protein F (CENPF) was elucidated. RESULTS: Hsa_circ_0002082 expression was higher in BC tissues and cell lines. Functionally, knockdown of hsa_circ_0002082 induced apoptosis and suppressed proliferation and metastasis in BC cells in vitro. Mechanistically, hsa_circ_0002082 targeted miR‐508‐3p, which was confirmed to be decreased in BC. MiR‐508‐3p overexpression suppressed BC cell malignant phenotypes, moreover, inhibition of miR‐508‐3p attenuated the anticancer action of hsa_circ_0002082 silencing on BC cells. Besides that, miR‐508‐3p targeted CENPF, CENPF was highly expressed in BC, CENPF up‐regulation reversed the suppressive impacts of miR‐508‐3p on BC cell growth and metastasis. Besides, hsa_circ_0002082 silencing impeded BC growth in nude mice. CONCLUSION: Knockdown of hsa_circ_0002082 suppresses breast cancer growth and metastasis by miR‐508‐3p/CENPF axis, suggesting that hsa_circ_0002082 may be a promising target for breast cancer treatment. John Wiley and Sons Inc. 2022-09-26 /pmc/articles/PMC9701879/ /pubmed/36161346 http://dx.doi.org/10.1002/jcla.24697 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Liu, Yu Liu, Yun Luo, Jinyong Zhao, Wen Hu, Chunhui Chen, Gongquan Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression |
title | Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression |
title_full | Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression |
title_fullStr | Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression |
title_full_unstemmed | Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression |
title_short | Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression |
title_sort | hsa_circ_0002082 up‐regulates centromere protein f via abolishing mir‐508‐3p to promote breast cancer progression |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701879/ https://www.ncbi.nlm.nih.gov/pubmed/36161346 http://dx.doi.org/10.1002/jcla.24697 |
work_keys_str_mv | AT liuyu hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression AT liuyun hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression AT luojinyong hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression AT zhaowen hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression AT huchunhui hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression AT chengongquan hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression |